Alnylam Pharmaceuticals, Inc. SEC Filings http://investors.alnylam.com/ Alnylam Pharmaceuticals, Inc. SEC Filings en 4: Statement of changes in beneficial ownership of securities http://investors.alnylam.com/sec-filings/sec-filing/4/0001735276-19-000048 ALNYLAM PHARMACEUTICALS, INC. Fri, 07 Jun 2019 16:08:44 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23871 4: Statement of changes in beneficial ownership of securities http://investors.alnylam.com/sec-filings/sec-filing/4/0001735276-19-000047 ALNYLAM PHARMACEUTICALS, INC. Fri, 07 Jun 2019 16:08:41 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23866 4: Statement of changes in beneficial ownership of securities http://investors.alnylam.com/sec-filings/sec-filing/4/0001735276-19-000044 ALNYLAM PHARMACEUTICALS, INC. Fri, 07 Jun 2019 16:06:47 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23861 4: Statement of changes in beneficial ownership of securities http://investors.alnylam.com/sec-filings/sec-filing/4/0001735276-19-000046 ALNYLAM PHARMACEUTICALS, INC. Fri, 07 Jun 2019 16:06:42 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23851 4: Statement of changes in beneficial ownership of securities http://investors.alnylam.com/sec-filings/sec-filing/4/0001735276-19-000045 ALNYLAM PHARMACEUTICALS, INC. Fri, 07 Jun 2019 16:06:42 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23856 8-K: Report of unscheduled material events or corporate event http://investors.alnylam.com/sec-filings/sec-filing/8-k/0001193125-19-152751 ALNYLAM PHARMACEUTICALS, INC. Tue, 21 May 2019 16:34:15 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23811 4: Statement of changes in beneficial ownership of securities http://investors.alnylam.com/sec-filings/sec-filing/4/0001553878-19-000002 ALNYLAM PHARMACEUTICALS, INC. Fri, 17 May 2019 16:11:00 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23806 SC 13G/A: An amendment to the SC 13G filing http://investors.alnylam.com/sec-filings/sec-filing/sc-13ga/0001193125-19-136912 ALNYLAM PHARMACEUTICALS, INC. Fri, 03 May 2019 16:08:02 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23786 CT ORDER: CT ORDER http://investors.alnylam.com/sec-filings/sec-filing/ct-order/9999999997-19-003727 ALNYLAM PHARMACEUTICALS, INC. Thu, 02 May 2019 17:12:19 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23781 10-Q: Quarterly report which provides a continuing view of a company's financial position http://investors.alnylam.com/sec-filings/sec-filing/10-q/0001564590-19-015366 ALNYLAM PHARMACEUTICALS, INC. Thu, 02 May 2019 16:38:15 -0400 Alnylam Pharmaceuticals, Inc. SEC Filings 23776